Breakthrough T1D Funded Investigators with New nPOD Projects:
Project Name: Identification of extrathymic Aire-expressing cells in human lymph nodes
PI: Mark Stuart Anderson, M.D., Ph.D., University of California, San Francisco
Project Name: Tracing effector and regulatory T-cell populations in type 1 diabetes
PI: Dolores Jaraquemada, Ph.D., Universitat Autonoma de Barcelona
Project Name: Risk of autoimmune diseases and human self-antigen expression
PI: Richard David Leslie, M.D, FRCP, University of London
Project Name: Sequencing the islet transcriptome
PI: Ivan Gerling, Ph.D., University of Tennessee, Memphis
Project Name: Evidence for increased numbers of stem cells in human T1D pancreas
PI: Leonard Harrison, D.Sc., Walter & Eliza Hall Institute of Medical Research
Project Name: Islet Resistance to T1D
PI: Clayton Mathews, Ph.D., University of Florida
Project Name: Detection of islet autoreactive CD8 T-cells in insulitis versus periphery
PI: Bart Roep, Ph.D., D.M., Leiden University
Project Name: Heparan sulfate levels mark the health status of human islet beta cells
PI: Charmaine Simeonovic, Ph.D., Australian National University
Project Name: Pathological changes associated with chronic RelB activation in T1D
PI: Ranjeny Thomas, MBBS, M.D., University of Queensland
Project Name: Extracellular matrix involvement in type I diabetes
PI: Thomas Wight, Ph.D., Benaroya Research Institute at Virginia Mason